Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell CarcinomaHui Luo, Guangqiang Zhao, Jin Lü et al.|JAMA|2021Cited by 821
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA studyShun Lü, Weiguo Su, Zhendong Chen et al.|Lung Cancer|2020Cited by 21
Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinomaWenyan Gao, Zhihua Liu|EBioMedicine|2024Cited by 9